Predictors of Left Ventricular Remodeling after Revascularized Acute Myocardial Infarction

1. Weisman HF, Bush DE, Mannisi JA, Bulkley BH. Global Cardiac Remodeling After Acute Myocardial Infarction: A Study in the Rat Model. J Am Coll Cardiol. 1985;5(6):1355-1362.10.1016/S0735-1097(85)80348-XSearch in Google Scholar

2. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.10.1016/j.jcmg.2010.10.008Search in Google Scholar

3. Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol. 1978;41(7):1127-1132.10.1016/0002-9149(78)90869-XSearch in Google Scholar

4. Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987;30(2):73-110.10.1016/0033-0620(87)90004-1Search in Google Scholar

5. Sutton MG, Sharpe N. Left Ventricular Remodeling After Myocardial Infarction — Pathophysiology and Therapy. Circulation. 2000;101(25):2981-2988.10.1161/01.CIR.101.25.2981Search in Google Scholar

6. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of Initial Infarct Size to Extent of Left Ventricular Remodeling in the Year After Acute Myocardial Infarction. J Am Coll Cardiol. 1995;25(3):567-573.10.1016/0735-1097(94)00431-OSearch in Google Scholar

7. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med. 1979;300(2):57-62.10.1056/NEJM197901113000202Search in Google Scholar

8. Erlebacher JA, Weiss JL, Eaton LW, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol. 1982;49(5):1120-1126.10.1016/0002-9149(82)90035-2Search in Google Scholar

9. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74(4):693-702.10.1161/01.CIR.74.4.6933757183Search in Google Scholar

10. Whittaker P, Boughner DR, Kloner RA. Role of collagen in acute myocardial infarct expansion. Circulation. 1991;84(5):2123-2134.10.1161/01.CIR.84.5.21231934383Search in Google Scholar

11. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol. 1995;25(3):567-573.10.1016/0735-1097(94)00431-OSearch in Google Scholar

12. van Gilst WH, Kingma JH, Peels KH, Dambrink JH, St John Sutton M. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol. 1996;28(1):114-121.10.1016/0735-1097(96)00113-1Search in Google Scholar

13. Dujardin KS, Enriquez-Sarano M, Rossi A, Bailey KR, Seward JB. Echocardiographic Assessment of Left Ventricular Remodeling: Are Left Ventricular Diameters Suitable Tools? J Am Coll Cardiol. 1997;30(6):1534-1541.10.1016/S0735-1097(97)00329-XSearch in Google Scholar

14. Gottdiener JS, Livengood SV, Meyer PA, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol. 1995;25(2):424-430.10.1016/0735-1097(94)00375-ZSearch in Google Scholar

15. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.10.1016/j.jcmg.2010.10.00821232712Search in Google Scholar

16. Marwick T. Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function. Heart. 2003;89(Suppl3):iii2–iii8.10.1136/heart.89.suppl_3.iii2187630014594869Search in Google Scholar

17. Mosca L, Barrett-Connor E, Kass Wenger N. Sex/Gender Differences in Cardiovascular Disease Prevention, What a Difference a Decade Makes. Circulation. 2011;124(19):2145–2154.10.1161/CIRCULATIONAHA.110.968792336205022064958Search in Google Scholar

18. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-Related Differences in Myocardial Remodeling. J Am Coll Cardiol. 2010;55(11):1057-1065.10.1016/j.jacc.2009.09.06520223363Search in Google Scholar

19. Ednei LA, Andrey JS, dos Santos AA, et al. Are there gender differences in left ventricular remodeling after myocardial infarction in rats? Rev Bras Cir Cardiovasc. 2015;30(1):70–76.Search in Google Scholar

20. Litwin SE, Katz SE, Litwin CM, Morgan JP, Douglas PS. Gender differences in postinfarction left ventricular remodeling. Cardiology. 1999;91(3):173-183.10.1159/00000690610516411Search in Google Scholar

21. Konstam MA, Udelson JE, Anand IS, Cohn JN. Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail. 2003;9(5):350-353.10.1054/j.cardfail.2003.09.00114583894Search in Google Scholar

22. Zornoff LAM, Matsubara BB, Matsubara LS, et al. Cigarette smoke exposure intensifies ventricular remodeling process following myocardial infarction. Arq Bras Cardiol. 2006;86(4):276-282Search in Google Scholar

23. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321(4):225-236.10.1097/00000441-200104000-0000311307864Search in Google Scholar

24. Messerli FH, Ventura HO, Reisin E, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation. 1982;66(1):55-60.10.1161/01.CIR.66.1.557083520Search in Google Scholar

25. Messerli FH. Cardiomyopathy of obesity: a not-so-Victorian disease. N Engl J Med. 1986;314:378-38010.1056/NEJM1986020631406082935738Search in Google Scholar

26. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol. 2006;98(1):116-2010.1016/j.amjcard.2006.01.06316784933Search in Google Scholar

27. Litwin SE. Cardiac Remodeling in Obesity Time for a New Paradigm. JACC Cardiovasc Imaging. 2010;3(3):275-7.10.1016/j.jcmg.2009.12.00420223424Search in Google Scholar

28. Avelar E, Cloward TV, Walker JM. Left Ventricular Hypertrophy in Severe Obesity Interactions Among Blood Pressure, Nocturnal Hypoxemia, and Body Mass. Hypertension. 2007;49(1):34-9.10.1161/01.HYP.0000251711.92482.1417130310Search in Google Scholar

29. Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709-1716.10.1093/eurheartj/ehm18417556348Search in Google Scholar

30. Park D-W, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019-2027.10.1001/jama.2014.1509525399277Search in Google Scholar

31. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57(1):84-95.10.1161/01.RES.57.1.843891127Search in Google Scholar

32. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319(2):80-86.10.1056/NEJM1988071431902042967917Search in Google Scholar

33. Sweet CS, Emmert SE, Stabilito II, Ribeiro LG. Increased survival in rats with congestive heart failure treated with enalapril. J Cardiovasc Pharmacol. 1987;10(6):636-642.10.1097/00005344-198712000-00005Search in Google Scholar

34. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial cfft’cts of loneterm therapy with captopril. Circulation. 1985;72(2):406-412.10.1161/01.CIR.72.2.406Search in Google Scholar

35. Jugdutt BI, Schwarz-Michorowski BL, Khan MI. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol. 1992;19(3):713-721.10.1016/S0735-1097(10)80298-0Search in Google Scholar

36. Pfeffer MA1, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-1172.10.1161/01.CIR.81.4.1161Search in Google Scholar

37. Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a topographic assessment using two-dimensional echocardiography. J Am Coll Cardiol. 1989;13(7):1506-1513.10.1016/0735-1097(89)90340-9Search in Google Scholar

38. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet. 1994;343(8906):1115-1122.Search in Google Scholar

39. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995;345(8951):669-685.10.1016/S0140-6736(95)90865-XSearch in Google Scholar